Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp425 | Osteoporosis: treatment | ECTS2013

Evaluation with densitometry of patients with breast cancer and low bone mineral density after 2 years of treatment

Gil Sonia Munoz , Dolera Tomas Mut , Lopez Belen C Garrido , Maicas M D Torregrosa , Sarrio R Girones , Tendero P Lopez , Armario M D Garcia , Mira Pascual Munoz

Aim: Evaluate the differences with densitometry after 2-year treatment in patients with breast cancer and LBMD.Materials and methods: A 2 year duration longitudinal study was done in patients diagnosed with breast cancer sent to the Rheumatology Osteoporosis Unit in Hospital d’Ontinyent, who required supplements of calcium and vitamin D+bisphosphonates after a risk fracture study. Socio-demographic data, breast tumor characteristics, risk f...

ba0003pp30 | Bone biomechanics and quality | ECTS2014

Strength training is capable of stimulating transcription factors Runx2 and osterix and ensure better bone quality in wistar rats during aging

Stringhetta-Garcia Camila Tami , Ervolino Edilson , Rossi Ana Claudia , Louzada Mario Jefferson Quirino , de Mello Wagner Garcez , Menegati Dornelles Rita Cassia

Osteoporosis is a multifactorial disease that represents an increase public health problem, given the impact on functional independence and quality of life. Among the favoring factors to the imbalance in bone cell activity, the hypoestrogenism is primordial. Strength training (ST) proves to be effective because of its ability to stimulate estrogen receptor independent of ligand. In this study, we analyzed the action of ST on bone quality of rats during the aging. For this stud...

ba0003pp124 | Cell biology: osteoblasts and bone formation | ECTS2014

MiR-320a and miR-483-5p are over-expressed in osteoblasts from osteoporotic fractured hips

Garcia-Giralt Natalia , De-Ugarte Laura , Balcells Susana , Arino-Ballester Sergi , Yoskovitz Guy , Guerri Roberto , Mellibovsky Leonardo , Urreizti Roser , Nogues Xavier , Grinberg Daniel , Diez-Perez Adolfo

MicroRNAs are important regulators of gene expression with documented role in bone metabolism and osteoporosis. Moreover, the use of miRNAs constitutes potential therapeutic targets. Our aim was to identify miRNAs differentially expressed in fractured compared to healthy bone. Additionally, we performed a miRNA profiling of primary osteoblasts to assess the origin of the differentially expressed miRNAs. Total RNA was extracted from fresh femoral neck trabecular bone from women...

ba0003pp192 | Genetics | ECTS2014

Genetic determinants of bone mineral density loss in aromatase inhibitors treatment in the B-ABLE Cohort

Rodriguez-Sanz Maria , Garcia-Giralt Natalia , Torres-del Pliego Elisa , Prieto-Alhambra Daniel , Servitja Sonia , Balcells Susana , Mellibovsky Leonardo , Grinberg Daniel , Tusquets Ignasi , Diez-Perez Adolfo , Nogues Xavier

Bone density (BMD) loss is a consequence of aromatase inhibitors (AI) treatment of breast cancer. B-ABLE cohort includes 391 postmenopausal women with early breast cancer starting AI therapy. Participants experienced a 1.98% (95% CI 1.54–2.42% P<0.0001) bone loss at lumbar spine (LS) and 1.24% (95% CI 0.81–1.67% P<0.0001) bone loss at femoral neck (FN) after 1 year on AI therapy and a 3.51% (95% CI 3.00–4.03% P<0.0001) bone...

ba0005p239 | Genetics and Epigenetics | ECTS2016

Search for BMD-related variants of DKK1 and SOST by resequencing in the BARCOS cohort

Martinez-Gil Nuria , Roca-Ayats Neus , Urreizti Roser , Franco-Valls Hector , Garcia-Giralt Natalia , Mellibovsky Leonardo , Nogues Xavier , Diez-Perez Adolfo , Grinberg Daniel , Balcells Susana

In a meta-analysis by Estrada et al. (2012), 56 loci were found associated with BMD, 14 of which were also associated with osteoporotic fracture. Several of these genes belong to the Wnt signaling pathway, including two inhibitors: DKK1 and SOST.To better understand the role of these genes in BMD determination and fracture susceptibility, we aimed to explore their allelic architecture by resequencing all coding exons and flanking region...

ba0001oc6.6 | Mineralisation and energy metabolism | ECTS2013

An emerging role of phospho1 in the regulation of energy metabolism

Oldknow Karla , Morton Nik Morton's , Yadav Manisha , Rajoanah Sophie , Huesa Carmen , Bunger Lutz , Ferron Mathieu , Karsenty Gerard , MacRae Vicky , Milan Jose Luis , Farquharson Colin

Genetic approaches to bone physiology utilising judicious gain and loss of function models have identified bone as an endocrine organ, being involved in the regulation of energy metabolism and reproduction. Recent advances expand our understanding and identify a new and unconventional role of bone beyond its classical functions. PHOSPHO1 is a bone specific phosphatase with a recognised role in bone mineralisation, but our present studies have now identified a novel role for PH...

ba0001pp104 | Calciotropic and phosphotropic hormones and mineral metabolism | ECTS2013

Neonatal neuroendocrine alterations impair tooth eruption, enamel mineralization, and leptin and corticosterone secretion in adulthood

de Mello Wagner Garcez , de Morais Samuel Rodrigues Lourenco , Delbem Alberto Carlos Botazzo , Dornelles Rita Cassia Menegati , Antunes-Rodrigues Jose , de Castro Joao Cesar Bedran

There is a growing body of evidence indicating the important role of the neonatal steroid milieu in programming sexually dimorphic pattern in various physiological systems. We tested the hypothesis that abnormal exposure to steroid hormones within a critical developmental period elicits permanent changes on tooth eruption, enamel mineralization, and leptin and corticosterone concentrations in adulthood. Newborn Wistar rats were divided into four groups, two male groups and two...

ba0003pp354 | Osteoporosis: treatment | ECTS2014

Denosumab treatment in women with osteoporosis reduces hip cortical porosity

Zebaze Roger M , Libanati Cesar , McClung Michael R , Zanchetta Jose R , Kendler David L , Hoiseth Arne , Wang Andrea , Ghasem-Zadeh Ali , Seeman Ego

Bone strength is influenced by cortical thickness, area, mass and porosity, all of which contribute to nonvertebral fracture risk. Cortical porosity is one parameter of structural decay associated with bone fragility. This is caused by unbalanced and accelerated remodelling of Haversian units which enlarge, coalesce and fragment the cortex. Antiresorptive therapies will limit progression of cortical porosity; reducing existing porosity would be a goal for those already at incr...